Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Lauren Carter, David Veesler, Neil King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong
doi: https://doi.org/10.1101/2022.03.30.22273143
Joon Young Song
1Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
MDWon Suk Choi
2Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea
MDJung Yeon Heo
3Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea
MDJin Soo Lee
4Division of Infectious Diseases, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea
MDDong Sik Jung
5Division of Infectious Diseases, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea
MDShin-Woo Kim
6Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
MDKyung-Hwa Park
7Division of Infectious Diseases, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea
MDJoong Sik Eom
8Division of Infectious Diseases, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea
MDSu Jin Jeong
9Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
MDJacob Lee
4Division of Infectious Diseases, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea
10Division of Infectious Diseases, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
MDKi Tae Kwon
11Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
MDHee Jung Choi
12Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea
MDJang Wook Sohn
13Division of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
MDYoung Keun Kim
14Division of Infectious Diseases, Department of Internal Medicine, Yonsei University Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
MDJi Yun Noh
1Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
MDWoo Joo Kim
1Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
MDFrançois Roman
15GlaxoSmithKline Vaccines, Wavre, Belgium
MDMaria Angeles Ceregido
15GlaxoSmithKline Vaccines, Wavre, Belgium
PhDFrancesca Solmi
15GlaxoSmithKline Vaccines, Wavre, Belgium
PhDAgathe Philippot
15GlaxoSmithKline Vaccines, Wavre, Belgium
PharmDLauren Carter
16Department of Biochemistry, University of Washington, WA, U.S.
18Institute for Protein Design, University of Washington, WA, U.S.
MSDavid Veesler
16Department of Biochemistry, University of Washington, WA, U.S.
17Howard Hughes Medical Institute, University of Washington, WA, U.S.
PhDNeil King
16Department of Biochemistry, University of Washington, WA, U.S.
18Institute for Protein Design, University of Washington, WA, U.S.
PhDHun Kim
19Department of R&D, SK Bioscience, Seongnam, Republic of Korea
PhDJi Hwa Ryu
19Department of R&D, SK Bioscience, Seongnam, Republic of Korea
MSSu Jeen Lee
19Department of R&D, SK Bioscience, Seongnam, Republic of Korea
PhDYong Wook Park
19Department of R&D, SK Bioscience, Seongnam, Republic of Korea
PhDHo Keun Park
19Department of R&D, SK Bioscience, Seongnam, Republic of Korea
BSHee Jin Cheong
1Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present work are contained in the manuscript.
Posted April 02, 2022.
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Lauren Carter, David Veesler, Neil King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong
medRxiv 2022.03.30.22273143; doi: https://doi.org/10.1101/2022.03.30.22273143
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Lauren Carter, David Veesler, Neil King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong
medRxiv 2022.03.30.22273143; doi: https://doi.org/10.1101/2022.03.30.22273143
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2629)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12181)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4070)
- Geriatric Medicine (387)
- Health Economics (678)
- Health Informatics (2627)
- Health Policy (998)
- Hematology (361)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3839)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (448)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)